Return On Equity of ImmunityBio, Inc. from 30 Sep 2020 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
ImmunityBio, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2020 to 31 Dec 2025.
- ImmunityBio, Inc. Return On Equity for the quarter ending 31 Dec 2025 was 64%, a 2% increase year-over-year.
- ImmunityBio, Inc. annual Return On Equity for 2025 was 64%, a 2% increase from 2024.
- ImmunityBio, Inc. annual Return On Equity for 2024 was 63%, a 41% decline from 2023.
- ImmunityBio, Inc. annual Return On Equity for 2023 was 107%, a 5.5% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
ImmunityBio, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | 64% | +1.3% | +2% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | 64% | -22% | -26% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | 61% | -39% | -39% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | 65% | -38% | -37% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | 63% | -44% | -41% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | 86% | -3.4% | -3.8% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | 100% | +8.1% | +8.8% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | 103% | +9.2% | +9.8% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | 107% | +5.6% | +5.5% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | 90% | -22% | -19% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | 92% | -34% | -27% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | 94% | -65% | -41% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | 102% | -77% | -43% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | 112% | -65% | -37% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | 126% | -81% | -39% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | 159% | -110% | -41% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | 178% | -245% | -58% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | 176% | -1477% | -89% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | 207% | 01 Apr 2021 | 30 Jun 2021 | ||
| Q1 2021 | 269% | 01 Jan 2021 | 31 Mar 2021 | ||
| Q4 2020 | 424% | 01 Oct 2020 | 31 Dec 2020 | ||
| Q3 2020 | 1653% | 01 Jul 2020 | 30 Sep 2020 |
ImmunityBio, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | 64% | +1.3% | +2% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | 63% | -44% | -41% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | 107% | +5.6% | +5.5% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | 102% | -77% | -43% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | 178% | -326% | -65% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | 505% | 01 Jan 2020 | 31 Dec 2020 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.